86 related articles for article (PubMed ID: 14626239)
21. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 replication without integration.
Dent Today; 2008 Sep; 27(9):56. PubMed ID: 18807952
[No Abstract] [Full Text] [Related]
23. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
24. Too high a cost for a cure?
Boyce N
US News World Rep; 2002 Oct; 133(14):34. PubMed ID: 12389521
[No Abstract] [Full Text] [Related]
25. Gene therapists hopeful as trials resume with childhood disease.
Check E
Nature; 2004 Jun; 429(6992):587. PubMed ID: 15190314
[No Abstract] [Full Text] [Related]
26. The future of gene therapy.
Cavazzana-Calvo M; Thrasher A; Mavilio F
Nature; 2004 Feb; 427(6977):779-81. PubMed ID: 14985734
[No Abstract] [Full Text] [Related]
27. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
[TBL] [Abstract][Full Text] [Related]
28. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.
Zeilfelder U; Frank O; Sparacio S; Schön U; Bosch V; Seifarth W; Leib-Mösch C
Gene; 2007 Apr; 390(1-2):175-9. PubMed ID: 17045761
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of HIV integration and therapeutic intervention.
Vandegraaff N; Engelman A
Expert Rev Mol Med; 2007 Feb; 9(6):1-19. PubMed ID: 17320002
[TBL] [Abstract][Full Text] [Related]
30. Centrosomal pre-integration latency of HIV-1 in quiescent cells.
Zamborlini A; Lehmann-Che J; Clave E; Giron ML; Tobaly-Tapiero J; Roingeard P; Emiliani S; Toubert A; de Thé H; Saïb A
Retrovirology; 2007 Sep; 4():63. PubMed ID: 17845727
[TBL] [Abstract][Full Text] [Related]
31. Vector integration: location, location, location.
Mok HP; Lever AM
Gene Ther; 2005 Jan; 12(1):1-2. PubMed ID: 15510174
[No Abstract] [Full Text] [Related]
32. The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients.
Erkeland SJ; Palande KK; Valkhof M; Gits J; Danen-van Oorschot A; Touw IP
Leuk Res; 2009 Oct; 33(10):1367-71. PubMed ID: 19327827
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy: X-SCID transgene leukaemogenicity.
Thrasher AJ; Gaspar HB; Baum C; Modlich U; Schambach A; Candotti F; Otsu M; Sorrentino B; Scobie L; Cameron E; Blyth K; Neil J; Abina SH; Cavazzana-Calvo M; Fischer A
Nature; 2006 Sep; 443(7109):E5-6; discussion E6-7. PubMed ID: 16988659
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy: shining hopes dented - but not dashed.
Check E
Nature; 2002 Dec 19-26; 420(6917):735. PubMed ID: 12490910
[No Abstract] [Full Text] [Related]
35. Genes can come true.
Phillips H
New Sci; 2002 Nov; 176(2371):30-3. PubMed ID: 12731520
[No Abstract] [Full Text] [Related]
36. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
Gansbacher B;
J Gene Med; 2003 Mar; 5(3):261-2. PubMed ID: 12666192
[No Abstract] [Full Text] [Related]
37. Gene therapy put on hold as third child develops cancer.
Check E
Nature; 2005 Feb; 433(7026):561. PubMed ID: 15703711
[No Abstract] [Full Text] [Related]
38. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
Couzin J; Kaiser J
Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
[No Abstract] [Full Text] [Related]
39. Early stages of HIV replication: how to hijack cellular functions for a successful infection.
Lehmann-Che J; Saïb A
AIDS Rev; 2004; 6(4):199-207. PubMed ID: 15700618
[TBL] [Abstract][Full Text] [Related]
40. [Gene therapy of children with X-linked severe combined immune deficiency: efficiency and complications].
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Med Sci (Paris); 2004 Jan; 20(1):115-7. PubMed ID: 14770374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
